Andrew Lawrence Taylor

CIK: 0001723889

Transaction Breakdown

Open Market Buys (P)2 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)9 (64.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OBIO

Orchestra BioMed Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

OBIO
Orchestra BioMed Holdings, Inc.
Aug 26, 2026
Tax Payment(F)
Direct
3.1K shares at avg. $5.26$16K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 10, 2026
Tax Payment(F)
Direct
36.4K shares at avg. $4.02$146K
OBIO
Orchestra BioMed Holdings, Inc.
May 28, 2026
Tax Payment(F)
Direct
3.1K shares at avg. $3.98$12K
OBIO
Orchestra BioMed Holdings, Inc.
Feb 12, 2026
Award(A)
Direct
181K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jan 2, 2026
Tax Payment(F)
Direct
3.5K shares at avg. $4.31$15K
OBIO
Orchestra BioMed Holdings, Inc.
Dec 10, 2025
Tax Payment(F)
Direct
8.7K shares at avg. $4.67$40K
OBIO
Orchestra BioMed Holdings, Inc.
Nov 25, 2025
Tax Payment(F)
Direct
3.1K shares at avg. $5.35$16K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 17, 2025
Tax Payment(F)
Direct
16.1K shares at avg. $2.46$40K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 25, 2025
Purchase(P)
Direct
2K shares at avg. $2.55$5K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Direct
80K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jun 11, 2025
Tax Payment(F)
Direct
28.2K shares at avg. $3.14$88K
OBIO
Orchestra BioMed Holdings, Inc.
Apr 4, 2025
Award(A)
Direct
84K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Dec 19, 2024
Purchase(P)
Direct
1K shares at avg. $4.83$5K
OBIO
Orchestra BioMed Holdings, Inc.
Dec 12, 2024
Tax Payment(F)
Direct
34.4K shares at avg. $5.03$173K

		Type	Shares	Price		Ownership
Aug 26, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,076	$5.26	$16,180	Direct
Jun 10, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	36,352	$4.02	$146,135	Direct
May 28, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,076	$3.98	$12,242	Direct
Feb 12, 2026	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	181,000	-	$0	Direct
Jan 2, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,452	$4.31	$14,878	Direct
Dec 10, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	8,670	$4.67	$40,489	Direct
Nov 25, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,071	$5.35	$16,430	Direct
Sep 17, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	16,102	$2.46	$39,611	Direct
Aug 25, 2025	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	2,000	$2.55	$5,100	Direct
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	80,000	-	-	Direct
Jun 11, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	28,172	$3.14	$88,460	Direct
Apr 4, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	84,000	-	-	Direct
Dec 19, 2024	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	1,000	$4.83	$4,830	Direct
Dec 12, 2024	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	34,403	$5.03	$173,047	Direct

1-14 of 14 transactions

About Taylor Andrew Lawrence

Taylor Andrew Lawrence (SEC CIK 0001723889) files insider reports with the SEC as Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO).

Signal8 holds 14 ownership filings by Taylor Andrew Lawrence, all Form 4s, filed between Dec 13, 2024 and Aug 28, 2026. Those filings report 14 transactions, from Dec 12, 2024 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Taylor Andrew Lawrence's filings is in NEW HOPE, PA.

Recent filings by Taylor Andrew Lawrence

Aug 26, 2026: Tax withholding of OBIO shares (Form 4, code F).
Jun 10, 2026: Tax withholding of OBIO shares (Form 4, code F).
May 28, 2026: Tax withholding of OBIO shares (Form 4, code F).
Feb 12, 2026: Grant or award of OBIO shares (Form 4, code A).
Jan 2, 2026: Tax withholding of OBIO shares (Form 4, code F).

Other insiders filing for Orchestra BioMed Holdings, Inc. (OBIO)

Sherman Darren
Hochman David P
Aiello Joshua, Principal Accounting Officer
Pacitti David, Director
Fain Eric S, Director
Mack John Prosper, Director

How to read Form 4 transaction codes